=99.9% FOR PURIFIED PERFLUORO-N-OCTANE REMAINS UNCHANGED.">
This medical device record is a pma supplement. A supplement may have changed the device description/function or indication from that approved in the original pma. Be sure to look at the original pma record for more information.
Elimination of finished product intravitreal testing for perfluoron and revision of the "purified perfluoro-n-octane analytical test monograph" regarding calculation of impurities. The specification of >=99. 9% for purified perfluoro-n-octane remains unchanged.
Device | PERFLUORON |
Generic Name | Fluid, Intraocular |
Applicant | ALCON LABORATORIES |
Date Received | 2001-07-13 |
Decision Date | 2001-08-07 |
PMA | P950018 |
Supplement | S007 |
Product Code | LWL |
Advisory Committee | Ophthalmic |
Supplement Type | 30-day Notice |
Supplement Reason | Process Change - Manufacturer/sterilizer/packager/supplier |
Expedited Review | No |
Combination Product | No |
Applicant Address | ALCON LABORATORIES 6201 South Freeway R3-48 fort Worth, TX 76134 |
Supplement Number | Date | Supplement Type |
---|---|---|
P950018 | Original Filing | |
S021 | 2022-07-18 | 30-day Notice |
S020 | 2021-10-26 | 30-day Notice |
S019 | 2020-06-29 | 30-day Notice |
S018 | 2015-03-26 | 30-day Notice |
S017 | ||
S016 | 2012-11-08 | Normal 180 Day Track |
S015 | 2012-01-30 | Real-time Process |
S014 | 2010-11-22 | 30-day Notice |
S013 | 2010-03-05 | 30-day Notice |
S012 | ||
S011 | 2009-07-14 | Normal 180 Day Track |
S010 | 2008-04-15 | Normal 180 Day Track No User Fee |
S009 | 2003-02-14 | Real-time Process |
S008 | 2001-12-26 | Real-time Process |
S007 | 2001-07-13 | 30-day Notice |
S006 | 2001-04-24 | 30-day Notice |
S005 | 2001-02-26 | 30-day Notice |
S004 | 2000-02-17 | Normal 180 Day Track |
S003 | 1999-03-26 | Normal 180 Day Track |
S002 | 1999-02-11 | Real-time Process |
S001 | 1996-10-17 | Normal 180 Day Track |
Device ID | PMA | Supp |
---|---|---|
00380659001642 | P950018 | 000 |
10380659001632 | P950018 | 000 |